What is Model Drug?
Established in 1989, Model Drug, also known as Model Health Care, is a family-owned entity that has grown to become the largest Long-Term Care Pharmacy in the valley. The company specializes in providing innovative pharmacy and nursing technology solutions tailored for long-term care facilities, hospice care, assisted living residences, and sub-acute care settings. A key differentiator for Model Drug is its adoption of advanced technology, notably being the sole pharmacy in California to utilize the AccuPac unit-dose automation and inspection packaging system. This commitment to cutting-edge solutions, combined with competitive pricing and exceptional customer service, defines its market position.
How much funding has Model Drug raised?
Model Drug has raised a total of $1.2M across 2 funding rounds:
Debt
$350K
Debt
$804K
Debt (2020): $350K with participation from PPP
Debt (2021): $804K led by PPP
What's next for Model Drug?
The substantial enterprise-level funding, including the recent major strategic investment, positions Model Drug for accelerated growth and further technological integration. This capital infusion is expected to bolster its capacity to serve a growing client base within the long-term care sector and potentially expand its service offerings. The company's focus on proprietary technology like AccuPac suggests a strategy centered on operational efficiency and enhanced patient care, which will likely be further developed with this new backing. Future developments may include scaling its technological infrastructure, expanding its geographic reach, and deepening its partnerships within the healthcare ecosystem.
See full Model Drug company page
